J.P. Morgan upgraded Elanco Animal Health (NYSE:ELAN) to Overweight from Neutral on Tuesday, arguing that the veterinary product maker is set to accelerate its revenue growth over the next few years ...
NEW YORK (CBS.MW) -- CIBC said the multiple sclerosis drug Tysabri, developed by Elan Corp. and Biogen Idec and approved by the Food and Drugs Administration on Tuesday is likely to become a ...
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. Elanco Animal Health Incorporated is one of them. Elanco Animal Health Incorporated (NYSE:ELAN) ...
Elan 295 cruiser-racer for sale in Cork. Equipped for racing and cruising, with extensive sail inventory and extras.
TipRanks on MSN
Elanco upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Elanco (ELAN) to Overweight from Neutral with a price target of $24, up from $18. The company is entering an “attractive ...
DUBLIN, April 22 (Reuters) - Irish drugmaker Elan said it was seeking a partnership with a big pharmaceutical company, after reporting a 14 percent rise in first-quarter revenues and a wider net loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback